跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
RADICAVA Edaravone 30mg/20mL concentrated injection ampoule
Approved
STANDARD
RADICAVA Edaravone 30mg/20mL concentrated injection ampoule
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e68b90f1c16c9f71
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e68b90f1c16c9f71
Product Name
RADICAVA Edaravone 30mg/20mL concentrated injection ampoule
Artg Id
375455
Artg Name
RADICAVA edaravone 30 mg/20 mL concentrated injection ampoule
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2023-02-15
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b33e306175af5448a78a004b28789f38.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/4ba42e32a27da05930df0b3c3f41ce4f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e68b90f1c16c9f71
Type
Standard
Back to TGA Approvals